Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia

被引：2

作者：

Niscola, Pasquale ^{[1
]}

Neri, Benedetta ^{[1
]}

Catalano, Gianfranco ^{[1
]}

Morino, Luciana ^{[1
]}

Giovannini, Marco ^{[1
]}

Scaramucci, Laura ^{[1
]}

Fratoni, Stefano ^{[2
]}

Noguera, Nelida Ines ^{[3
]}

Cordone, Iole ^{[4
]}

de Fabritiis, Paolo ^{[1
]}

机构：

[1] S Eugenio Hosp, Hematol Unit, Rome, Italy

[2] S Eugenio Hosp, Pathol Unit, Rome, Italy

[3] Santa Lucia Fdn, Neuro Oncohematol Unit, Rome, Italy

[4] Regina Elena Inst Canc Res, Clin Pathol, Rome, Italy

来源：

ACTA ONCOLOGICA | 2017年 / 56卷 / 08期

关键词：

OLDER PATIENTS; 1ST-LINE TREATMENT; PHASE-III; MULTICENTER; CHEMOTHERAPY; TRIAL; UNFIT;

D O I：

10.1080/0284186X.2017.1287947

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1120 / 1121

页数：2

共 15 条

[1] Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy [J].

Bhatnagar, Bhavana ;

Duong, Vu H. ;

Gourdin, Theodore S. ;

Tidwell, Michael L. ;

Chen, Ching ;

Ning, Yi ;

Emadi, Ashkan ;

Sausville, Edward A. ;

Baer, Maria R. .

LEUKEMIA & LYMPHOMA, 2014, 55 (07) :1533-1537

[2] Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia [J].

Cashen, Amanda F. ;

Schiller, Gary J. ;

O'Donnell, Margaret R. ;

DiPersio, John F. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :556-561

[3] Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J].

Cheson, BD ;

Bennett, JM ;

Kopecky, KJ ;

Büchner, T ;

Willman, CL ;

Estey, EH ;

Schiffer, CA ;

Döhner, H ;

Tallman, MS ;

Lister, TA ;

LoCocco, F ;

Willemze, R ;

Biondi, A ;

Hiddemann, W ;

Larson, RA ;

Löwenberg, B ;

Sanz, MA ;

Head, DR ;

Ohno, R ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4642-4649

[4] Decitabine reduces transfusion dependence in older patients with acute myeloid leukemia: results from a post hoc analysis of a randomized phase III study [J].

He, Jianming ;

Xiu, Liang ;

De Porre, Peter ;

Dass, Ramesh ;

Thomas, Xavier .

LEUKEMIA & LYMPHOMA, 2015, 56 (04) :1033-1042

[5] Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia [J].

Kantarjian, Hagop M. ;

Thomas, Xavier G. ;

Dmoszynska, Anna ;

Wierzbowska, Agnieszka ;

Mazur, Grzegorz ;

Mayer, Jiri ;

Gau, Jyh-Pyng ;

Chou, Wen-Chien ;

Buckstein, Rena ;

Cermak, Jaroslav ;

Kuo, Ching-Yuan ;

Oriol, Albert ;

Ravandi, Farhad ;

Faderl, Stefan ;

Delaunay, Jacques ;

Lysak, Daniel ;

Minden, Mark ;

Arthur, Christopher .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2670-2677

[6] Pharmacokinetic and pharmacodynamic analysis of 5-aza-2′-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy [J].

Karahoca, Metin ;

Momparler, Richard L. .

CLINICAL EPIGENETICS, 2013, 5

[7] Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy [J].

Lazzarotto, Davide ;

Candoni, Anna ;

Nadali, Gianpaolo ;

Pavan, Laura ;

Lessi, Federica ;

Mosna, Federico ;

Simeone, Erica ;

Ventura, Giovanna ;

Gherlinzoni, Filippo ;

Semenzato, Gianpietro ;

Pizzolo, Giovanni ;

Fanin, Renato .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (06) :586-592

[8] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy [J].

Luebbert, Michael ;

Rueter, Bjoern H. ;

Claus, Rainer ;

Schmoor, Claudia ;

Schmid, Mathias ;

Germing, Ulrich ;

Kuendgen, Andrea ;

Rethwisch, Volker ;

Ganser, Arnold ;

Platzbecker, Uwe ;

Galm, Oliver ;

Brugger, Wolfram ;

Heil, Gerhard ;

Hackanson, Bjoern ;

Deschler, Barbara ;

Doehner, Konstanze ;

Hagemeijer, Anne ;

Wijermans, Pierre W. ;

Doehner, Hartmut .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03) :393-401

[9] Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia [J].

Meldi, Kristen ;

Qin, Tingting ;

Buchi, Francesca ;

Droin, Nathalie ;

Sotzen, Jason ;

Micol, Jean-Baptiste ;

Selimoglu-Buet, Dorothee ;

Masala, Erico ;

Allione, Bernardino ;

Gioia, Daniela ;

Poloni, Antonella ;

Lunghi, Monia ;

Solary, Eric ;

Abdel-Wahab, Omar ;

Santini, Valeria ;

Figueroa, Maria E. .

JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (05) :1857-1872

[10] The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use [J].

Nieto, Maria ;

Demolis, Pierre ;

Behanzin, Eliane ;

Moreau, Alexandre ;

Hudson, Ian ;

Flores, Beatriz ;

Stemplewski, Henry ;

Salmonson, Tomas ;

Gisselbrecht, Christian ;

Bowen, David ;

Pignatti, Francesco .

ONCOLOGIST, 2016, 21 (06) :692-700

← 1 2 →